Chardan Positive on StemCells (STEM) Following Interview with Dr. Armin Curt; Reaffirms 'Buy' Rating
Tweet Send to a Friend
StemCells (Nasdaq: STEM) is positive early following a recent conference call with Chardan Capital.Analyst Ling Wang and others spoke with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
